Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Accelerated Versus Standard Regiment of Hepatitis B Virus Vaccine Among Inflammatory Bowel Disease Patients
NCT05967650Completed
- Sponsor
- Assiut University
- Start
- Jan 2025
- Primary completion
- Mar 2026
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Randomised trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by Assiut University. Primary endpoint: Frequency of IBD patients with negative HBs Ab at 2 months. Started Jan 2025; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT05967650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05967650.